MyCelx Technologies (GB:MYX) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
MyCelx Technologies Corporation reported its H1 2024 financial results, highlighting the sale of its Saudi Arabian operations for $3.125 million, a gross profit margin of 28.2%, and a net loss of $1.4 million. The company has seen significant operational advancements, notably in its PFAS and REGEN media technologies, securing various contracts and trials, which forecasts a promising outlook into 2025. Additionally, MyCelx successfully raised approximately $0.9 million in equity to further its trials and potentially secure more contracts in the growing PFAS remediation and EOR markets.
For further insights into GB:MYX stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue